These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22740340)

  • 1. New revised FIGO 2008 staging system for endometrial cancer produces better discrimination in survival compared with the 1988 staging system.
    Kato T; Watari H; Endo D; Mitamura T; Odagiri T; Konno Y; Hosaka M; Kobayashi N; Todo Y; Sudo S; Takeda M; Dong P; Kaneuchi M; Kudo M; Sakuragi N
    J Surg Oncol; 2012 Dec; 106(8):938-41. PubMed ID: 22740340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does the revised International Federation of Gynecology and Obstetrics staging system for endometrial cancer lead to increased discrimination in patient outcomes?
    Cooke EW; Pappas L; Gaffney DK
    Cancer; 2011 Sep; 117(18):4231-7. PubMed ID: 21387282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphadenectomy increases the prognostic value of the revised 2009 FIGO staging system for endometrial cancer: a multi-center study.
    Kim HS; Kim HY; Park CY; Lee JM; Lee JK; Cho CH; Kim SM; Kim JW
    Eur J Surg Oncol; 2012 Mar; 38(3):230-7. PubMed ID: 22244682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of prognostic evaluation of International Federation of Gynecology and Obstetrics 2009 staging system on stage I endometrioid adenocarcinoma].
    Wang ZQ; Zhang Y; Wang JL; Shen DH; Mu T; Zhao X; Yao YY; Bai Y; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):33-9. PubMed ID: 22455691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revision of FIGO surgical staging in 2009 for endometrial cancer validates to improve risk stratification.
    Werner HM; Trovik J; Marcickiewicz J; Tingulstad S; Staff AC; Amant F; Salvesen HB;
    Gynecol Oncol; 2012 Apr; 125(1):103-8. PubMed ID: 22100838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Impact of 2009 FIGO staging system on the diagnostic value of preoperative MRI staging of endometrial carcinoma].
    Yu XD; Ouyang H; Lin M; Zhou CW; Zhang R
    Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):692-6. PubMed ID: 22340052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FIGO stage IIIC endometrial carcinoma: prognostic factors and outcomes.
    Hoekstra AV; Kim RJ; Small W; Rademaker AW; Helenowski IB; Singh DK; Schink JC; Lurain JR
    Gynecol Oncol; 2009 Aug; 114(2):273-8. PubMed ID: 19428094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the new FIGO 2009 staging classification for vulvar cancer on prognosis and stage distribution.
    Tabbaa ZM; Gonzalez J; Sznurkowski JJ; Weaver AL; Mariani A; Cliby WA
    Gynecol Oncol; 2012 Oct; 127(1):147-52. PubMed ID: 22704951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
    Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
    Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
    Ma SK; Zhang HT; Sun YC; Wu LY
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
    Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
    Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR staging accuracy for endometrial cancer based on the new FIGO stage.
    Shin KE; Park BK; Kim CK; Bae DS; Song SY; Kim B
    Acta Radiol; 2011 Sep; 52(7):818-24. PubMed ID: 21742787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial carcinoma: clinical characteristic and survival rates by the new compared to the prior FIGO staging systems.
    Tangjitgamol S; Srijaipracharoen S; Manusirivithaya S; Khunnarong J; Pataradool K; Thavaramara T
    J Med Assoc Thai; 2013 May; 96(5):505-12. PubMed ID: 23745302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic significance of age in surgically staged patients with Type II endometrial carcinoma.
    Vance S; Yechieli R; Cogan C; Hanna R; Munkarah A; Elshaikh MA
    Gynecol Oncol; 2012 Jul; 126(1):16-9. PubMed ID: 22507535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Endometrial adenocarcinoma treated with combined radiotherapy and surgery: 437 cases].
    Touboul E; Belkacémi Y; Buffat L; Deniaud-Alexandre E; Lefranc JP; Lhuillier P; Uzan S; Jannet D; Uzan M; Antoine M; Ginesty C; Ganansia V; Jamali M; Milliez J; Blondon J; Schlienger M
    Cancer Radiother; 2001 Aug; 5(4):425-44. PubMed ID: 11521391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nodal distribution and its significance in FIGO stage IIIc endometrial cancer.
    McMeekin DS; Lashbrook D; Gold M; Scribner DR; Kamelle S; Tillmanns TD; Mannel R
    Gynecol Oncol; 2001 Aug; 82(2):375-9. PubMed ID: 11531298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A suggested modification to FIGO stage I endometrial cancer.
    Aristizabal P; Graesslin O; Barranger E; Clavel-Chapelon F; Haddad B; Luton D; Darai E; Rouzier R; Koskas M
    Gynecol Oncol; 2014 May; 133(2):192-6. PubMed ID: 24631453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy.
    Nelson G; Randall M; Sutton G; Moore D; Hurteau J; Look K
    Gynecol Oncol; 1999 Nov; 75(2):211-4. PubMed ID: 10525373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter analysis of adjuvant therapy after surgery for stage IIIC endometrial adenocarcinoma: A Korean Radiation Oncology Group study (KROG 13-17).
    Yoon MS; Park W; Huh SJ; Kim HJ; Kim YS; Kim YB; Kim JY; Lee JH; Kim HJ; Cha J; Kim JH; Kim J; Yoon WS; Choi JH; Chun M; Choi Y; Chang SK; Lee KK; Kim M
    Gynecol Oncol; 2015 Sep; 138(3):519-25. PubMed ID: 26115977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.